| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2006 | US20060020035 Bone marrow protection with N-acetyl-L-cysteine |
| 01/26/2006 | US20060020034 Processes for the preparation of Gabapentin |
| 01/26/2006 | US20060020033 Method for treating dermatological viral infections |
| 01/26/2006 | US20060020032 Animal composition |
| 01/26/2006 | US20060020031 Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses |
| 01/26/2006 | US20060020030 Health food or a dietary supplement, food or beverage product, eye disease, cardiovascular disease, cancer |
| 01/26/2006 | US20060020029 Pharmaceutical compositions from ethnobotanicals |
| 01/26/2006 | US20060020028 Levodopa prodrugs, and compositions and uses thereof |
| 01/26/2006 | US20060020027 Use of curcumanoids as histone acetyltransferases (HATs) inhibitors |
| 01/26/2006 | US20060020026 Form of ferric citrate; soluble over a wider range of pH, have large active surface area; hyperphosphatemia, metabolic disorders; acidosis; reacting NaOH with ferric chloride hexahydrate to form a uniform colloidal suspension of Fe(OH)3, then react with citric acid |
| 01/26/2006 | US20060020025 Mixture with vehicle; topical applying |
| 01/26/2006 | US20060020024 TNP-470 species, polymer conjugates and use thereof |
| 01/26/2006 | US20060020023 Racemization method |
| 01/26/2006 | US20060020022 Enantioselective separation method |
| 01/26/2006 | US20060020021 Use of compounds derived from 2,3-dehydronaringenin for the treatment of inflammatory processes and pharmaceutical composition containing said derivatives |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060020019 Such as 1-(3,5-bis(trifluoromethyl)benzyloxy)-3-(dimethylamino)-2-phenylpropan-2-ol, trifluoroacetic acid salt for treating a disorder associated with aberrant levels of tachykinins or serotonin; depression, obsessive compulsive disorder, bulimia, or panic disorder |
| 01/26/2006 | US20060020018 Side effect reduction; hot flashes, vaginal dryness, osteopenia and osteoporosis; cancers and hyperplasia of the breast, endometrium, cervix and prostate endometriosis, uterine fibroids, osteoarthritis, contraceptive agents; 8-Hydroxy-1,4-dithia-spiro[4.5]dec-7-ene-7-carboxylic Acid Methyl Ester |
| 01/26/2006 | US20060020017 Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
| 01/26/2006 | US20060020016 5-Ethoxy-4-(1-(benzyloxycarbonyl)-2-pyrrolidinylcarbonylamino)-5H-furan-2-one; purification by chromatography, selectively crystallization, or dynamic crystallization; useful for preparing caspase inhibitors |
| 01/26/2006 | US20060020015 Method for treating nervous system disorders and conditions |
| 01/26/2006 | US20060020014 Method for treating nervous system disorders and conditions |
| 01/26/2006 | US20060020013 Control of arthropods in animals |
| 01/26/2006 | US20060020012 Pyrazole derivatives |
| 01/26/2006 | US20060020011 Diseases mediated by tachykinins and for seritonin reuptake transporter protein as reuptake inhibitors |
| 01/26/2006 | US20060020010 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/26/2006 | US20060020009 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060020007 Compositions containing policosanol and biotin and their pharmaceutical uses |
| 01/26/2006 | US20060020006 less side effects; higher potency; chronic and neuropathic pain, epilepsy, manic depression, bipolar disorder, diabetic neuropathy; 3-[3-(2-Trifluoromethoxyphenyl)-phenyl]-1,2,4-triazole |
| 01/26/2006 | US20060020005 Process for preparing losartan |
| 01/26/2006 | US20060020004 Isoxazolidine compounds for treatment of bacterial infections |
| 01/26/2006 | US20060020003 Biphenyloxy-acids |
| 01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
| 01/26/2006 | US20060020001 Use of cathepsin k inhibitors for the treatment of glaucoma |
| 01/26/2006 | US20060020000 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019998 Histamine-3 receptor antagonist |
| 01/26/2006 | US20060019997 Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019995 2,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same |
| 01/26/2006 | US20060019994 I-sulphonlyl piperidine derivatives |
| 01/26/2006 | US20060019993 Esterifying aromatic hydroxy group, converting secondary hydroxy group to a leaving group (sulfonation), and intramolecularly cyclizing; esterifying the OH group of an o-alkoxyphenol with an N-glycidyl-amide or imide and deprotecting the remaining OH group. |
| 01/26/2006 | US20060019992 Cycloalkylamine derivatives as NK-1/SSRI antagonists |
| 01/26/2006 | US20060019991 Pulmonary diseases, asthma, chronic obstructive pulmonary disease, chronic bronchitis, physema; pre-term labor, neurological and cardiac disorders; improved duration of action, potency, selectivity; 8-hydroxy-5-((R)-1-hydroxy-2-{2-[4-(6-methoxybiphenyl-3-yloxy)phenyl]-ethylamino}ethyl)-1H-quinolin-2-one |
| 01/26/2006 | US20060019990 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 01/26/2006 | US20060019989 Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof |
| 01/26/2006 | US20060019988 Compounds, compositions, and methods |
| 01/26/2006 | US20060019987 Methods and compositions for inhibiting, destroying, and/or inactivating viruses |
| 01/26/2006 | US20060019986 (R/S) rifamycin derivatives, their preparations and pharmaceutical compositions |
| 01/26/2006 | US20060019985 For therapy and prophylaxis of infectious diseases in mammals, both humans and non-humans, having antibacterial activity against drug-resistant bacteria |
| 01/26/2006 | US20060019984 Treatment of diseases with alpha-7nACh receptor full agonists |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019981 Reacting ethyl-1-(3-acetylenylphenyl)-1,4-dihydro(1,8)naphthyridin-4-one-3-carboxylate with 3- bromopyridine in palladium catalyst, phosphine ligand and amine base, and them amidating the ester with cyclopropylamine; one pot process |
| 01/26/2006 | US20060019980 Methods for treating or preventing erectile dysfunction or urinary incontinence |
| 01/26/2006 | US20060019979 Method for the selective preparation of 3-oxo-4-aza-5a androstane compound |
| 01/26/2006 | US20060019978 Spirocyclic compounds useful as modulators of nuclear hormone receptor function |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019976 Methods for treating Hepatitis C |
| 01/26/2006 | US20060019975 Novel piperidyl derivatives of quinazoline and isoquinoline |
| 01/26/2006 | US20060019974 4-Amino-quinazolines |
| 01/26/2006 | US20060019973 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 01/26/2006 | US20060019972 Methods of treating cancer by inhibiting histone gene expression |
| 01/26/2006 | US20060019971 Treatment of cardiovascular disease with inhibitors of p38 kinase |
| 01/26/2006 | US20060019970 Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites |
| 01/26/2006 | US20060019969 Use of compounds active on the sigma receptor for the treatment of allodynia |
| 01/26/2006 | US20060019968 Use of compounds active on the sigma receptor for the treatment of neuropathic pain |
| 01/26/2006 | US20060019967 SARS CoV main protease inhibitors |
| 01/26/2006 | US20060019966 Method for treating nervous system disorders and conditions |
| 01/26/2006 | US20060019965 Gonadotropin releasing hormone receptor antagonists |
| 01/26/2006 | US20060019964 Compounds |
| 01/26/2006 | US20060019963 Compounds |
| 01/26/2006 | US20060019962 Modulators of muscarinic receptors |
| 01/26/2006 | US20060019961 Estrogen receptor ligands |
| 01/26/2006 | US20060019960 Antitumoral analogs of ET-743 |
| 01/26/2006 | US20060019959 Novel quinoxalinone derivatives |
| 01/26/2006 | US20060019958 Immunity-related protein kinase inhibitors |
| 01/26/2006 | US20060019957 Imidazotriazines as protein kinase inhibitors |
| 01/26/2006 | US20060019956 Compositions useful as inhibitors of rock and other protein kinases |
| 01/26/2006 | US20060019955 4,5-dihydroxy-2-methyl-benzoic acid 2-(2,2-dimethyl-cyclopropanecarbonyloxy)-3-{1,1-dimethyl-2-[(tetrahydro-furan-3-carbonyl)-amino]-ethylamino}-propyl ester; glaucoma, ocular hypertension, or optic neuropathy |
| 01/26/2006 | US20060019954 Method for reducing the likelihood of the occurrence of cardiac arrhythmias |
| 01/26/2006 | US20060019953 Pyridine inhibitors of ERK2 and uses thereof |
| 01/26/2006 | US20060019952 Anti-viral therapeutics |
| 01/26/2006 | US20060019951 Vacuolins |
| 01/26/2006 | US20060019950 Benzathiazol-acetamides |
| 01/26/2006 | US20060019949 Alzheimer's disease, Parkinson's disease, Huntington's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, ADHD, drug addiction, such as amphetamine, cocaine, opioids, ethanol, nicotine, cannabinoids; asthma, allergic responses, hypoxia, cardiovasular disorders |
| 01/26/2006 | US20060019948 Methylidene-D-xylopyranosyl- and oxo-D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 01/26/2006 | US20060019947 Therapeutic chromone compounds |
| 01/26/2006 | US20060019946 3-(4-Piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019944 Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists |
| 01/26/2006 | US20060019943 Homopiperidine derivatives as NK-1 antagonists |
| 01/26/2006 | US20060019942 Metal complex glycogen synthase kinase 3 inhibitors |
| 01/26/2006 | US20060019941 Prophylaxis or prevention of aberrations in a signal transduction pathway mediated by a cKit kinase by administering 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents |
| 01/26/2006 | US20060019940 Novel benzoxazocines and their therapeutic use |
| 01/26/2006 | US20060019939 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 01/26/2006 | US20060019938 Estrogen administration for treating male cognitive dysfunction or improving male cognitive function |
| 01/26/2006 | US20060019937 Novel crystalline forms of 6alpha, 9alpha -difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene 17beta-carboxylic acid and processes for preparation thereof |
| 01/26/2006 | US20060019936 Methods and compositions for treating cancer |